Ergoteles LLC Amneal Pharmaceuticals, Inc. Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.02 - $3.62 $35,873 - $64,287	17,759 New	17,759 $36,000
Q3 2021 Nov 15, 2021	SELL	$4.31 - $5.64 $83,182 - $108,852	-19,300 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$5.12 - $6.82 $98,816 - $131,626	19,300 New	19,300 $99,000
Q4 2020 Feb 11, 2021	SELL	$3.95 - $5.42 $41,680 - $57,191	-10,552 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.54 - $5.27 $37,354 - $55,609	10,552 New	10,552 $41,000

183

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.21B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.